Dividendos de Hubei Biocause Heilen Pharmaceutical
Dividendo controles de criterios 2/6
Hubei Biocause Heilen Pharmaceutical is a dividend paying company with a current yield of 2.34%.
Información clave
2.3%
Rentabilidad por dividendo
n/a
Rendimiento de la recompra
| Rendimiento total para el accionista | n/a |
| Rendimiento futuro de los dividendos | n/a |
| Crecimiento de los dividendos | n/a |
| Próxima fecha de pago de dividendos | n/a |
| Fecha ex dividendo | n/a |
| Dividendo por acción | CN¥0.480 |
| Ratio de pago | 130% |
Últimas actualizaciones de dividendos
Recent updates
Hubei Biocause Heilen Pharmaceutical's (SZSE:301211) Shareholders Have More To Worry About Than Lackluster Earnings
Nov 04
Earnings Not Telling The Story For Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SZSE:301211) After Shares Rise 43%
Oct 30Earnings Not Telling The Story For Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SZSE:301211)
Aug 07Hubei Biocause Heilen Pharmaceutical (SZSE:301211) Will Pay A Larger Dividend Than Last Year At CN¥0.48
May 22Hubei Biocause Heilen Pharmaceutical's (SZSE:301211) Promising Earnings May Rest On Soft Foundations
Apr 29Estabilidad y crecimiento de los pagos
Obteniendo datos sobre dividendos
Dividendo estable: Whilst dividend payments have been stable, 301211 has been paying a dividend for less than 10 years.
Dividendo creciente: 301211's dividend payments have increased, but the company has only paid a dividend for 2 years.
Rentabilidad por dividendo vs. Mercado
| Rentabilidad por dividendo de Hubei Biocause Heilen Pharmaceutical vs. Mercado |
|---|
| Segmento | Rentabilidad por dividendo |
|---|---|
| Empresa (301211) | 2.3% |
| Suelo de mercado 25% (CN) | 0.6% |
| Techo de mercado 25% (CN) | 2.2% |
| Media de la industria (Pharmaceuticals) | 1.7% |
| Analista de previsiones (301211) (hasta 3 años) | n/a |
Dividendo destacado: 301211's dividend (2.34%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
Alto dividendo: 301211's dividend (2.34%) is in the top 25% of dividend payers in the CN market (2.22%)
Pago de beneficios a los accionistas
Cobertura de los beneficios: With its high payout ratio (129.8%), 301211's dividend payments are not well covered by earnings.
Pago en efectivo a los accionistas
Cobertura de flujo de caja: 301211 is paying a dividend but the company has no free cash flows.